Literature DB >> 7356511

Correlation of the production of plasminogen activator with tumor metastasis in B16 mouse melanoma cell lines.

B S Wang, G A McLoughlin, J P Richie, J A Mannick.   

Abstract

The correlation between the production of plasminogen activator (PA) of tumors and their metastatic potential was studied. B16 melanoma cells and "B16 mets" cells (harvested from the pulmonary metastatic nodules of C57BL/6J mice bearing B16 isografts) were examined with respect to their fibrinolytic activity (FA) in tissue culture. B16 mets cells had a significantly higher FA than did B16 cells. F1 (a B16 subline with a lower incidence of metastasis) and F10 (a highly metastatic B16 subline) were also studied. F10 cells produced more FA than did F1 cells. The difference between the FA's of these tumors was due to differences in their PA production. Significant differences in PA production between F1 and F10 could be consistently observed when 10(5) or more cells were cultured for at least 24 hr. The cell-free supernatants harvested from 72-hr cultures of F10 cells had a higher FA than those harvested from F1 cultures. Results suggest that a quantitative difference in PA production between these 2 melanoma sublines does exist and that it may contribute to their different metastatic potential.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7356511

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  26 in total

Review 1.  Modification of the metastatic potential of tumor cells by drugs.

Authors:  K Takenaga
Journal:  Cancer Metastasis Rev       Date:  1986       Impact factor: 9.264

Review 2.  The role of proteolytic enzymes in cancer invasion and metastasis.

Authors:  M J Duffy
Journal:  Clin Exp Metastasis       Date:  1992-05       Impact factor: 5.150

3.  Expression of human recombinant plasminogen activators enhances invasion and experimental metastasis of H-ras-transformed NIH 3T3 cells.

Authors:  J H Axelrod; R Reich; R Miskin
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

4.  Low-molecular-weight membrane component inhibits the metastatic phenotype of B16-F10 melanoma.

Authors:  Z Keren; S J LeGrue
Journal:  Clin Exp Metastasis       Date:  1989 May-Jun       Impact factor: 5.150

Review 5.  Studies on rat mammary adenocarcinomas: a model for metastasis.

Authors:  I A Ramshaw; P Badenoch-Jones
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

6.  Proteolytic and metastatic activities of clones derived from a methylcholanthrene-induced murine fibrosarcoma.

Authors:  M E McLaughlin; I E Liener; N Wang
Journal:  Clin Exp Metastasis       Date:  1983 Oct-Dec       Impact factor: 5.150

7.  The effect of butyric acid and retinoic acid on invasion and experimental metastasis of murine melanoma cells.

Authors:  T W McGarvey; S Silberman; B Persky
Journal:  Clin Exp Metastasis       Date:  1990 Sep-Oct       Impact factor: 5.150

8.  Heterogeneities of attachment, chemotaxis, and protease production among clones with different metastatic potentials from a human pancreatic cancer cell line.

Authors:  S Taniguchi; T Iwamura; N Kitamura; H Yamanari; T Setoguchi
Journal:  Clin Exp Metastasis       Date:  1994-05       Impact factor: 5.150

9.  DMSO-induced changes in the procoagulant and fibrinolytic activity of B16 melanoma cells: influence on lung colony formation.

Authors:  B Casali; M G Lampugnani; M Riganti; A Niewiarowska; G Alessio; L Mussoni; N Semeraro; M B Donati
Journal:  Clin Exp Metastasis       Date:  1988 Sep-Oct       Impact factor: 5.150

10.  Heterogeneity of isozyme expression in tumor cells does not correlate with metastatic potential.

Authors:  S L Aukerman; M J Siciliano; I J Fidler
Journal:  Clin Exp Metastasis       Date:  1986 Jul-Sep       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.